← Leaderboards
Daniel Evan Bauer
Boston Children'S Hospital
$19,160,492
Attributed
$33,571,461
Total exposure
14
Grants
12
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $6.5M · FY2012–25$10M$7.5M$5M$2.5M$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$33,571,461 · 14
By mechanism
R01$16,295,020 · 7
UM1$8,671,281 · 1
DP2$2,655,000 · 1
OT2$2,603,282 · 1
P01$1,584,878 · 1
U01$856,513 · 1
Top collaborators
- Luca Pinello8 shared
- Richard I Sherwood5 shared
- Guillaume Lettre4 shared
- Peter E Newburger4 shared
- Scot A Wolfe4 shared
- Pietro Genovese3 shared
- Nathan D Pankratz3 shared
- Alexander P Reiner3 shared
Most similar at Boston Children'S Hospital
Same institution · by research overlap
- Joel N Hirschhorn$22,642,169
- Scot A Wolfe$14,652,054
- Nan Liu$181,500
- Danilo Pellin$285,504
Others in their field
Top investigators on “Genes”
- David Heimbrook · Leidos Biomedical Research, Inc.$413,811,031
- Richard A Gibbs · Baylor College Of Medicine$338,750,128
- Barton F Haynes · Duke University$304,076,400
- Stacey Gabriel · Massachusetts Institute Of Technology$241,252,013
- Eric S Lander · Whitehead Institute For Biomedical Res$211,825,987
- Richard K. Wilson · Washington University$195,881,965
Research focus
GenesCellsHematological DiseaseDesignChromatinRegulationFetal HemoglobinGenome EditingHemoglobinGenome Wide Association StudyMediatingGeneticSpecificityErythrocytesRegulatory ElementVariantMolecularGene ExpressionErythroidHematologyTechnologyAllelesMutationSickle Cell Anemia
Grant awards (43)
Comprehensive characterization of variants underlying heart and blood diseases with CRISPR base editing$1,890,246
UM1 · FY2025 · HG
In vivo hematopoietic stem cell genetic modification by viral particles$874,907
R01 · FY2025 · HL · contact PI
Robust verification of genetic variant-associated candidate off-target sites$856,513
U01 · FY2025 · AI · contact PI
Chemotherapy-free cure of hemoglobin disorders through base editing$766,048
R01 · FY2025 · HL · contact PI
Computational tools for precision genome editing$751,289
R01 · FY2025 · HG · contact PI
Structural Variation and Hematological Traits$694,774
R01 · FY2025 · HL
Targeting ZNF410 for HbF reactivation$672,403
R01 · FY2025 · HL · contact PI
Comprehensive characterization of variants underlying heart and blood diseases with CRISPR base editing$1,890,246
UM1 · FY2024 · HG
In vivo hematopoietic stem cell genetic modification by viral particles$889,998
R01 · FY2024 · HL · contact PI
Computational tools for precision genome editing$802,221
R01 · FY2024 · HG · contact PI
Chemotherapy-free cure of hemoglobin disorders through base editing$760,457
R01 · FY2024 · HL · contact PI
Structural Variation and Hematological Traits$687,693
R01 · FY2024 · HL
Targeting ZNF410 for HbF reactivation$658,954
R01 · FY2024 · HL · contact PI
Comprehensive characterization of variants underlying heart and blood diseases with CRISPR base editing$1,928,820
UM1 · FY2023 · HG
Rectifying splicing mutations in blood disorders by gene editing$855,537
R01 · FY2023 · HL · contact PI
Chemotherapy-free cure of hemoglobin disorders through base editing$807,747
R01 · FY2023 · HL · contact PI
Gene editing ELANE to understand and treat severe congenital neutropenia$766,145
R01 · FY2023 · HL · contact PI
Structural Variation and Hematological Traits$765,621
R01 · FY2023 · HL
Targeting ZNF410 for HbF reactivation$691,653
R01 · FY2023 · HL · contact PI
Comprehensive characterization of variants underlying heart and blood diseases with CRISPR base editing$1,928,820
UM1 · FY2022 · HG
Rectifying splicing mutations in blood disorders by gene editing$861,736
R01 · FY2022 · HL · contact PI
Gene editing ELANE to understand and treat severe congenital neutropenia$731,290
R01 · FY2022 · HL · contact PI
Comprehensive characterization of variants underlying heart and blood diseases with CRISPR base editing$1,033,149
UM1 · FY2021 · HG
Therapeutic BCL11A enhancer gene editing to induce fetal hemoglobin in β-hemoglobinopathy patients$886,788
OT2 · FY2021 · HL · contact PI
Rectifying splicing mutations in blood disorders by gene editing$866,772
R01 · FY2021 · HL · contact PI
Gene editing ELANE to understand and treat severe congenital neutropenia$735,635
R01 · FY2021 · HL · contact PI
Project 4 Functional Dissection of Erythroid Super-Enhancer, Daniel E. Bauer$317,577
P01 · FY2021 · HL · contact PI
Therapeutic BCL11A enhancer gene editing to induce fetal hemoglobin in β-hemoglobinopathy patients$1,716,494
OT2 · FY2020 · HL · contact PI
Rectifying splicing mutations in blood disorders by gene editing$890,593
R01 · FY2020 · HL · contact PI
Gene editing ELANE to understand and treat severe congenital neutropenia$763,547
R01 · FY2020 · HL · contact PI
Project 4 Functional Dissection of Erythroid Super-Enhancer, Daniel E. Bauer$317,577
P01 · FY2020 · HL · contact PI
Project 4 Functional Dissection of Erythroid Super-Enhancer, Daniel E. Bauer$317,577
P01 · FY2019 · HL · contact PI
Project 4 Functional Dissection of Erythroid Super-Enhancer, Daniel E. Bauer$317,577
P01 · FY2018 · HL · contact PI
Project 4 Functional Dissection of Erythroid Super-Enhancer, Daniel E. Bauer$314,570
P01 · FY2017 · HL · contact PI
Identification of sequences and factors required for HbF repression$88,500
R03 · FY2017 · DK · contact PI
High-throughput discovery of essential noncoding sequences for erythropoiesis$2,655,000
DP2 · FY2016 · HL · contact PI
Epigenetic regulation of BCL11A in the hemoglobin switch$156,276
K08 · FY2016 · DK · contact PI
Identification of sequences and factors required for HbF repression$88,500
R03 · FY2016 · DK · contact PI
Identification of sequences and factors required for HbF repression$49,092
R03 · FY2016 · DK · contact PI
Epigenetic regulation of BCL11A in the hemoglobin switch$124,675
K08 · FY2015 · DK · contact PI
Epigenetic regulation of BCL11A in the hemoglobin switch$124,675
K08 · FY2014 · DK · contact PI
Epigenetic regulation of BCL11A in the hemoglobin switch$124,675
K08 · FY2013 · DK · contact PI
Epigenetic regulation of BCL11A in the hemoglobin switch$149,094
K08 · FY2012 · DK · contact PI